To ensure that any differences in cerebral glucose metabolism between genotypes and sporadic ALS patients were not driven by population diversity, we matched C9orf72-ALS and SOD1-ALS patients to our cohort of sporadic ALS patients, using propensity score matching. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.